Diamyd Medical AB Share Price Nasdaq Stockholm
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- SEK | - |
Sales 2018 | - | Sales 2019 | - | Capitalization | 1.03B 10.95B 80.64B |
---|---|---|---|---|---|
Net income 2018 | 25M 267M 1.96B | Net income 2019 | 77M 821M 6.05B | EV / Sales 2018 | - |
Net cash position 2018 | 253M 2.7B 19.85B | Net cash position 2019 | 83.08M 886M 6.52B | EV / Sales 2019 | - |
P/E ratio 2018 |
28.3
x | P/E ratio 2019 |
13.3
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 68.13% |
1st Jan change | Capi. | |
---|---|---|
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |